curasan

AT A GLANCE.

curasan develops, manufactures and distributes biomaterials for bone and tissue regeneration. Our proven technologies have set standards of care in dental as well as in orthopedic, trauma and spinal surgery around the globe. But we haven’t finshed yet, and the best is yet to come. Our spin-off novaxomx researches and develops growth factors based on exosomes – a revolutionary approach to faster and better healing.

We represent a strong portfolio for dental and orthopedic surgery based on clinical evidence and great brands:

CERASORB®
CERACELL®
OSBONE®
OSGIDE®

Under the CERASORB® umbrella brand, we have established an innovative product line for bone and tissue regeneration. The phase purity of the β-tricalcium phosphate we produce and use in CERASORB® is considered the reference standard* in the market worldwide.
Our products are first choice of orthopedists, trauma and spine surgeons, sports physicians, as well as implantologists, oral and maxillofacial surgeons and specialists in surgical dentistry.

Our innovative products are certified by many international authorities and are available in around 50 countries worldwide.

*International Center of Diffraction Data, USA, ICDD 55-898

This global presence, with a major part of the business in Europe, the USA, China and Japan, is continuously strengthened and expanded by the more than 30 employees at the company headquarters in Frankfurt am Main and our subsidiary curasan, Inc. in Wake Forest, North Carolina USA.

New path.

Founded in 2022 as a joint venture between curasan AG and Xlife Sciences AG, novaxomx GmbH focuses on the research, development, certification, production and commercialization of disruptive biosurgical therapies for musculoskeletal diseases and tissue regeneration. It´s ambition is to improve the biofunctionality of carriers in regenerative processes through biologization with exosomes. With clinically proven products, novaxomx offers an innovative biologization option that targets bone regeneration and can be used even more effectively.